These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 2474178)

  • 1. Vasoactive intestinal peptide inhibits the respiratory burst in human monocytes by a cyclic AMP-mediated mechanism.
    Wiik P
    Regul Pept; 1989 May; 25(2):187-97. PubMed ID: 2474178
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of VIP on the respiratory burst in human monocytes ex vivo during prolonged strain and energy deficiency.
    Wiik P; Haugen AH; Løvhaug D; Bøyum A; Opstad PK
    Peptides; 1989; 10(4):819-23. PubMed ID: 2555797
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Receptors for vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide in turkey cerebral cortex: characterization by [125I]-VIP binding and effects on cyclic AMP synthesis.
    Zawilska JB; Niewiadomski P; Nowak JZ
    Gen Comp Endocrinol; 2004 Jun; 137(2):187-95. PubMed ID: 15158130
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vasoactive intestinal peptide stimulates androgen biosynthesis by cultured neonatal testicular cells.
    Kasson BG; Lim P; Hsueh AJ
    Mol Cell Endocrinol; 1986 Nov; 48(1):21-9. PubMed ID: 2430845
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Secretin and vasoactive intestinal peptide are potent stimulants of cellular contraction and accumulation of cyclic AMP in rat ventricular cardiomyocytes.
    Bell D; McDermott BJ
    J Cardiovasc Pharmacol; 1994 Jun; 23(6):959-69. PubMed ID: 7523789
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vasoactive intestinal peptide enhances phorbol myristate acetate-induced chemiluminescence in human lymphocytes.
    Lopez-Gonzalez MA; Guerrero JM; Lucas M
    Life Sci; 1992; 51(23):1803-10. PubMed ID: 1331643
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Stimulatory effect of vasoactive intestinal peptide (VIP) on cyclic AMP production in rat peritoneal macrophages.
    Segura JJ; Guerrero JM; Goberna R; Calvo JR
    Regul Pept; 1992 Feb; 37(3):195-203. PubMed ID: 1372999
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vasoactive intestinal peptide inhibits fMLP-induced respiratory burst in human lymphocytes.
    Bellido L; López-González MA; Pedrera C; Lucas M
    Life Sci; 1994; 54(24):1909-16. PubMed ID: 8196509
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vasoactive intestinal polypeptide-related peptides modulate tyrosine hydroxylase gene expression in PC12 cells through multiple adenylate cyclase-coupled receptors.
    Wessels-Reiker M; Basiboina R; Howlett AC; Strong R
    J Neurochem; 1993 Mar; 60(3):1018-29. PubMed ID: 8094740
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vasoactive intestinal polypeptide and alpha 2-adrenoceptor agonists regulate adenosine 3',5'-monophosphate accumulation and melatonin release in chick pineal cell cultures.
    Pratt BL; Takahashi JS
    Endocrinology; 1989 Nov; 125(5):2375-84. PubMed ID: 2477231
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Homologous regulation of vasoactive intestinal peptide (VIP) receptors on rat peritoneal macrophages.
    Pozo D; Guerrero JM; Calvo JR
    Peptides; 1995; 16(2):313-8. PubMed ID: 7784261
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effects of VIP on cyclic AMP and glycogen levels in vertebrate retina.
    Schorderet M; Hof P; Magistretti PJ
    Peptides; 1984; 5(2):295-8. PubMed ID: 6089132
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interaction of peptides related to VIP and secretin with guinea pig pancreatic acini.
    Zhou ZC; Gardner JD; Jensen RT
    Am J Physiol; 1989 Feb; 256(2 Pt 1):G283-90. PubMed ID: 2465694
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vasoactive intestinal polypeptide inhibits c-myc expression and growth of human gastric carcinoma cells.
    Kim SW; Beauchamp RD; Townsend CM; Thompson JC
    Surgery; 1991 Aug; 110(2):270-5; discussion 276. PubMed ID: 1713357
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interaction of thymic peptide thymosin alpha 1 with VIP receptors in rat intestinal epithelial cells: comparison with PHI and secretin.
    Calvo JR; Guerrero JM; Goberna R
    Gen Pharmacol; 1989; 20(4):503-5. PubMed ID: 2546855
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Secretin stimulates cyclic AMP formation in the rat brain.
    Fremeau RT; Korman LY; Moody TW
    J Neurochem; 1986 Jun; 46(6):1947-55. PubMed ID: 3009718
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Membrane currents elicited by porcine vasoactive intestinal peptide (VIP) in follicle-enclosed Xenopus oocytes.
    Woodward RM; Miledi R
    Proc R Soc Lond B Biol Sci; 1987 Sep; 231(1265):489-97. PubMed ID: 2447588
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Activation of the cAMP-generating system by vasoactive intestinal polypeptide (VIP) in the human laryngeal malignant cell line HEp-2.
    Prost A; Emami S; Rosselin G; Gespach C
    Biosci Rep; 1984 Dec; 4(12):1045-50. PubMed ID: 6085015
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vasoactive intestinal peptide (VIP) inhibits substrate adherence capacity of rat peritoneal macrophages by a mechanism that involves cAMP.
    Segura JJ; Guerrero JM; López-Gonzalez MA; Calvo JR
    Cell Adhes Commun; 1993 Dec; 1(3):213-21. PubMed ID: 7521755
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interaction of vasoactive intestinal peptide with isolated intestinal epithelial cells from rat. 2. Characterization and structural requirements of the stimulatory effect of vasoactive intestinal peptide on production of adenosine 3':5'-monophosphate.
    Laburthe M; Prieto JC; Amiranoff B; Dupont C; Hui Bon Hoa D; Rosselin G
    Eur J Biochem; 1979 May; 96(2):239-48. PubMed ID: 88368
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.